SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030786
Filing Date
2019-08-08
Accepted
2019-08-08 16:14:56
Documents
69
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aimt-10q_20190630.htm   iXBRL 10-Q 3027465
2 EX-10.5 aimt-ex105_180.htm EX-10.5 909290
3 EX-10.6 aimt-ex106_531.htm EX-10.6 39288
4 EX-10.7 aimt-ex107_179.htm EX-10.7 297313
5 EX-31.1 aimt-ex311_6.htm EX-31.1 19447
6 EX-31.2 aimt-ex312_7.htm EX-31.2 19450
7 EX-32.1 aimt-ex321_8.htm EX-32.1 16884
8 GRAPHIC graxqul23o04000001.jpg GRAPHIC 21340
9 GRAPHIC graxqul23o04000002.jpg GRAPHIC 49277
10 GRAPHIC graxqul23o04000003.jpg GRAPHIC 51703
11 GRAPHIC gp2rrzdrtv5w000001.jpg GRAPHIC 6085
  Complete submission text file 0001564590-19-030786.txt   11366315

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA aimt-20190630.xsd EX-101.SCH 56342
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aimt-20190630_cal.xml EX-101.CAL 80002
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aimt-20190630_def.xml EX-101.DEF 168010
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE aimt-20190630_lab.xml EX-101.LAB 491146
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aimt-20190630_pre.xml EX-101.PRE 353597
17 EXTRACTED XBRL INSTANCE DOCUMENT aimt-10q_20190630_htm.xml XML 1921269
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37519 | Film No.: 191009681
SIC: 2834 Pharmaceutical Preparations